C.M. Bidwell & Associates’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q4
Sell
-2,956
Closed -$204K 273
2014
Q3
$204K Buy
+2,956
New +$204K 0.05% 149